Oxyindole derivatives as 5ht4 receptor agonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/14 (2006.01) A61K 31/454 (2006.01) A61P 1/04 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01)

Patent

CA 2598536

This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: A, R1 , R2, R3 , R4 and R5 are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by 5-HT4 agonisitic activity such as, but not limited to, as gastroesophageal reflux disease, gastrointestinal disease, gastric motility disorder, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome (IBS), constipation, dyspepsia, esophagitis, gastroesophageral disease, nausea, central nervous system disease, Alzheimer's disease, cognitive disorder, emesis, migraine, neurological disease, pain, cardiovascular disorders, cardiac failure, heart arrhythmia, diabetes or apnea syndrome.

L'invention concerne des composés de formule (I) ou un de leurs sels pharmaceutiquement acceptables où : A, R1, R2, R3, R4 et R5 sont décrits dans la description, ou un sel pharmaceutiquement acceptable, et des compositions contenant ces composés ainsi que leur utilisation dans le traitement d'un état à médiation par une activité de récepteur 5-HT4 tel que (mais de façon non restrictive) le reflux oeso-gastrique, la maladie gastro-intestinale, le trouble de motilité gastrique, la dyspepsie non ulcéreuse, la dyspepsie fonctionnelle, le syndrome du côlon irritable (IBS), la constipation, la dyspepsie, l'oesophagite, la maladie oeso-gastrique, la nausée, la maladie du système nerveux central, la maladie d'Alzheimer, le trouble cognitif, le vomissement, la migraine, le trouble neurologique, la douleur, les troubles cardiovasculaires, l'insuffisance cardiaque, l'arythmie, le diabète et le syndrome d'apnée

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oxyindole derivatives as 5ht4 receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxyindole derivatives as 5ht4 receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxyindole derivatives as 5ht4 receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1700284

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.